Whitehawk Therapeutics (WHWK) Revenue (2018 - 2025)
Whitehawk Therapeutics (WHWK) posted quarterly Revenue of $7.1 million for Q1 2025, up 33.48% year-over-year from $5.4 million in Q1 2024, and down 1.3% quarter-over-quarter from $7.2 million in Q4 2024.
Whitehawk Therapeutics (WHWK) Revenue (2018 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Revenue for 7 consecutive years, with $7.1 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Revenue rose 33.48% year-over-year to $7.1 million; the TTM figure through Dec 2025 stood at $7.1 million (down 72.5% YoY), while the FY2025 annual figure was $7.1 million, down 72.5% from the prior year.
- Revenue declined to $7.1 million in Q1 2025 per WHWK's latest filing, from $7.2 million in the prior quarter.
- Across five years, Revenue topped out at $14.0 million in Q4 2021 and bottomed at $120000.0 in Q1 2021.
- Historically, Revenue has averaged $5.8 million across 5 years, with a median of $6.0 million in 2023.
- On a YoY basis, Revenue climbed as much as 1822.5% in 2022 and fell as far as 62.66% in 2022.
- Whitehawk Therapeutics' Revenue stood at $14.0 million in 2021, then sank by 62.66% to $5.2 million in 2022, then rose by 21.03% to $6.3 million in 2023, then advanced by 14.43% to $7.2 million in 2024, then slipped by 1.3% to $7.1 million in 2025.
- Business Quant data shows WHWK's Revenue at $7.1 million in Q1 2025, $7.2 million in Q4 2024, and $7.2 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 7.15 Mn |
| Dec 31, 2024 | 7.24 Mn |
| Sep 30, 2024 | 7.21 Mn |
| Jun 30, 2024 | 6.18 Mn |
| Mar 31, 2024 | 5.35 Mn |
| Dec 31, 2023 | 6.33 Mn |
| Sep 30, 2023 | 5.96 Mn |
| Jun 30, 2023 | 6.20 Mn |
| Mar 31, 2023 | 5.87 Mn |
| Dec 31, 2022 | 5.23 Mn |
| Sep 30, 2022 | 4.25 Mn |
| Jun 30, 2022 | 3.44 Mn |
| Mar 31, 2022 | 2.31 Mn |
| Dec 31, 2021 | 14.00 Mn |
| Mar 31, 2021 | 120,000.00 |
| Dec 31, 2020 | 14.00 Mn |
| Sep 30, 2020 | 231,000.00 |
| Jun 30, 2020 | 15.00 Mn |
| Dec 31, 2018 | 2,144.00 |
| Sep 30, 2018 | 18.82 Mn |